FDG-PET/CT Diagnosis of Prosthetic Valve Endocarditis via Antibiotic-Associated Overanticoagulation

A medical case report published in the journal Cureus describes a complex diagnostic journey where a patient’s prosthetic valve endocarditis (PVE) was identified following an unexpected reaction to antibiotic treatment. The case highlights how antibiotic-associated overanticoagulation served as a clinical catalyst, eventually leading to a definitive diagnosis through the use of fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT).

Prosthetic valve endocarditis is a severe infection of the endocardium and the artificial valve material. It’s often more difficult to diagnose than native valve endocarditis because the prosthetic materials can create imaging artifacts that obscure the view of the infection during standard cardiac scans.

The Role of Overanticoagulation in Diagnosis

In the reported case, the patient experienced a significant spike in anticoagulation levels while receiving antibiotics. This phenomenon, known as overanticoagulation, occurs when certain medications interfere with the metabolism or efficacy of blood-thinning agents, such as warfarin.

The interaction between specific antibiotics and anticoagulants can lead to an abnormally high International Normalized Ratio (INR), increasing the risk of hemorrhage. In this instance, the instability caused by the overanticoagulation acted as a diagnostic trigger, prompting clinicians to investigate the underlying cause of the patient’s deteriorating condition more aggressively.

This clinical “unmasking” allowed the medical team to look beyond the initial symptoms and consider the possibility of an occult infection on the prosthetic valve, which had previously remained undetected.

Overcoming Imaging Limitations with FDG-PET/CT

Traditional diagnostic tools for endocarditis, such as transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE), are the primary first-line assessments. However, these methods often struggle to provide clear images of prosthetic valves due to the density of the artificial materials, which can hide small vegetations or abscesses.

To resolve the diagnostic uncertainty, clinicians employed FDG-PET/CT. This imaging technique utilizes a radioactive glucose analog, fluorodeoxyglucose, which is preferentially taken up by cells with high metabolic activity, including the activated macrophages and neutrophils found at sites of infection, and inflammation.

The FDG-PET/CT scan provided clear evidence of metabolic activity around the prosthetic valve, confirming the presence of endocarditis. This provided the necessary evidence to pivot the patient’s treatment plan toward a targeted approach for PVE.

Medical Context and Clinical Implications

The interaction between antibiotics and anticoagulants is a known risk in cardiovascular medicine. Many broad-spectrum antibiotics can alter the gut microbiota that produce vitamin K or inhibit the cytochrome P450 enzymes in the liver responsible for breaking down anticoagulants. This leads to an accumulation of the drug in the bloodstream, resulting in excessive thinning of the blood.

The significance of this case lies in the intersection of three distinct medical challenges: the difficulty of detecting PVE, the risk of drug-drug interactions, and the utility of advanced molecular imaging.

• Prosthetic valves provide a surface for bacterial biofilm formation, making them susceptible to persistent infections.
• Standard echocardiography may yield false-negative results in prosthetic cases.
• FDG-PET/CT offers a higher sensitivity for detecting inflammation in the valve ring and surrounding tissue.

The case underscores the necessity of a multidisciplinary approach when treating patients with prosthetic heart valves, particularly when they are prescribed complex medication regimens that include both anticoagulants and antibiotics.

While FDG-PET/CT is a powerful tool, medical literature generally suggests its use as a complementary diagnostic aid rather than a replacement for echocardiography, as it identifies inflammation rather than the structural anatomy of the valve.